Regeneron Pharmaceuticals (REGN) recently made a significant upside breakout. Pretty amazing for a stock that has more than doubled in the past 12 months. Let's go over our charts and indicators so we can show you what we mean.
More from Investing
The retailer, like many others, reported numbers that were not as bad as expected and rewarded investors as a result.
Be cautious if considering this stock, the bullish case is not clear.
Given there is little price history as yet, things are looking positive so far for sustainable building products firm, AZEK.
With Sino-U.S. relations approaching an all-time low, trade negotiators will chat by video link in an attempt to get the "Phase 1" deal back on track.